These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26002761)

  • 21. Rotigotine improves restless legs syndrome: a 6-month randomized, double-blind, placebo-controlled trial in the United States.
    Hening WA; Allen RP; Ondo WG; Walters AS; Winkelman JW; Becker P; Bogan R; Fry JM; Kudrow DB; Lesh KW; Fichtner A; Schollmayer E;
    Mov Disord; 2010 Aug; 25(11):1675-83. PubMed ID: 20629075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of augmentation of restless legs syndrome with rotigotine: a 1-year observational study.
    Trenkwalder C; Canelo M; Lang M; Schroeder H; Kelling D; Berkels R; Schollmayer E; Heidbrede T; Benes H
    Sleep Med; 2017 Feb; 30():257-265. PubMed ID: 26896370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breakthrough symptoms during the daytime in patients with restless legs syndrome (Willis-Ekbom disease).
    Tzonova D; Larrosa O; Calvo E; Granizo JJ; Williams AM; de la Llave Y; García-Borreguero D
    Sleep Med; 2012 Feb; 13(2):151-5. PubMed ID: 22281003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome.
    Splinter MY
    Ann Pharmacother; 2007 Feb; 41(2):285-95. PubMed ID: 17213296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany.
    Stiasny-Kolster K; Berg D; Hofmann WE; Berkels R; Grieger F; Lauterbach T; Schollmayer E; Bachmann CG
    Sleep Med; 2013 Jun; 14(6):475-81. PubMed ID: 23668924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rotigotine Transdermal Patch: A Review in Restless Legs Syndrome.
    Garnock-Jones KP
    Drugs; 2016 Jul; 76(10):1031-40. PubMed ID: 27324269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rotigotine transdermal patch in moderate to severe idiopathic restless legs syndrome: a randomized, placebo-controlled polysomnographic study.
    Oertel WH; Benes H; Garcia-Borreguero D; Högl B; Poewe W; Montagna P; Ferini-Strambi L; Sixel-Döring F; Trenkwalder C; Partinen M; Saletu B; Polo O; Fichtner A; Schollmayer E; Kohnen R; Cassel W; Penzel T; Stiasny-Kolster K
    Sleep Med; 2010 Oct; 11(9):848-56. PubMed ID: 20813583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotigotine in the treatment of primary restless legs syndrome: A meta-analysis of randomized placebo-controlled trials.
    Ding J; Fan W; Chen HH; Yan P; Sun SG; Zheng J
    J Huazhong Univ Sci Technolog Med Sci; 2015 Apr; 35(2):169-175. PubMed ID: 25877347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal rotigotine for the perioperative management of restless legs syndrome.
    Högl B; Oertel WH; Schollmayer E; Bauer L
    BMC Neurol; 2012 Sep; 12():106. PubMed ID: 23009552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of rotigotine transdermal system in adolescents with idiopathic restless legs syndrome (Willis-Ekbom disease).
    Elshoff JP; Hudson J; Picchietti DL; Ridel K; Walters AS; Doggett K; Moran K; Oortgiesen M; Ramirez F; Schollmayer E
    Sleep Med; 2017 Apr; 32():48-55. PubMed ID: 28366342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome.
    Benitez A; Edens H; Fishman J; Moran K; Asgharnejad M
    Ann N Y Acad Sci; 2014 Nov; 1329():45-66. PubMed ID: 25145951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and treatment of augmentation in patients with restless legs syndrome: practical recommendations.
    Geyer J; Bogan R
    Postgrad Med; 2017 Sep; 129(7):667-675. PubMed ID: 28818004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study.
    Inoue Y; Shimizu T; Hirata K; Uchimura N; Ishigooka J; Oka Y; Ikeda J; Tomida T; Hattori N;
    Sleep Med; 2013 Nov; 14(11):1085-91. PubMed ID: 24055212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch.
    Högl B; Oertel WH; Stiasny-Kolster K; Geisler P; Beneš H; García-Borreguero D; Trenkwalder C; Poewe W; Schollmayer E; Kohnen R
    BMC Neurol; 2010 Sep; 10():86. PubMed ID: 20920156
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy, safety and risk of augmentation of rotigotine for treating restless legs syndrome.
    Inoue Y; Hirata K; Hayashida K; Hattori N; Tomida T; Garcia-Borreguero D;
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():326-33. PubMed ID: 23103551
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Blood Pressure Dipping in Restless Legs Syndrome With Rotigotine: A Randomized Trial.
    Chenini S; Rassu AL; Barateau L; Lopez R; Carlander B; Guiraud L; Jaussent I; Dauvilliers Y
    Mov Disord; 2020 Dec; 35(12):2164-2173. PubMed ID: 32875658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome.
    Schreglmann SR; Gantenbein AR; Eisele G; Baumann CR
    Parkinsonism Relat Disord; 2012 Feb; 18(2):207-9. PubMed ID: 22030321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
    Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
    Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADMET considerations for restless leg syndrome drug treatments.
    de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1247-61. PubMed ID: 22808933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT.
    Bauer A; Cassel W; Benes H; Kesper K; Rye D; Sica D; Winkelman JW; Bauer L; Grieger F; Joeres L; Moran K; Schollmayer E; Whitesides J; Carney HC; Walters AS; Oertel W; Trenkwalder C;
    Neurology; 2016 May; 86(19):1785-93. PubMed ID: 27164714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.